CrossChx, the leader in healthcare identity, today declared it has increased a $15 million Series C financing round. Participants involve Silicon Valley Bank, Khosla Ventures, Drive Capital, NCT Ventures and Moonshots Capital. The financing will be utilized to aggressively expand sales and distribution of Queue, the company's flagship patient sign-in system used in hundreds of sites across the country.
"Queue finally offers a way for sufferers to safely log in to healthcare, giving contributors the capability to deliver a more personable level of care and returning control of sufferer identities back to their rightful owners – the patients themselves," stated Sean Lane, Founder and CEO of CrossChx. "Queue signals a new era of patient registration, and this capital will offer the resources to fulfill demand and expand across the country."
Since its founding in the year 2012, CrossChx has signed more than 350 health systems nationwide and made more than 50 million distinctive patient IDs for healthcare.
"Few companies in healthcare have acquired as much progress as rapidly as CrossChx," claimed Chris Olsen, Partner with Drive Capital. "We are continually inspired by the company's passionate, revolutionary approach to creating patient-centered, data-rich solutions that make better the processes for everyone, and we are glad to play a role in its future."
The Queue patient sign-in system is equipped with the company's identity resolution software that accurately captures patient information, deduplicates records, catches errors in patient medical profiles, and verifies patients' identities to prevent medical mistakes.
No comments:
Post a Comment